Multidimensional Vascular Aging Assessment: Perioperative assessment of vascular aging-related indicators, including noninvasive vascular assessments, hemodynamic measurements, and relevant clinical and laboratory variables. The assessment is observational and will not determine the treatment, surgical procedure, or perioperative management assigned to participants.
Study summary
This prospective observational cohort study will enroll adult patients undergoing cardiac surgery at Nanjing First Hospital, Nanjing Medical University. The study will evaluate multidimensional vascular aging markers before surgery and assess their association with postoperative acute kidney injury within 7 days after surgery. No intervention will be assigned by the study protocol, and all perioperative management will follow routine clinical practice.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Adult patients aged 18 years or older.
* Patients scheduled to undergo cardiac surgery at Nanjing First Hospital, Nanjing Medical University.
* Patients who are able to provide written informed consent.
* Patients who are expected to undergo perioperative vascular aging assessment and postoperative renal function monitoring according to the study protocol.
Exclusion Criteria:
* Patients younger than 18 years.
* Patients with preoperative end-stage renal disease or maintenance dialysis.
* Patients who are unable to complete the study-specified vascular aging assessment.
* Patients who decline participation or withdraw informed consent.
Primary outcome measure(s)
Incidence of Postoperative Acute Kidney Injury Within 7 Days After Surgery — From the date of surgery to postoperative day 7 Postoperative acute kidney injury will be assessed within 7 days after surgery according to predefined diagnostic criteria based on postoperative renal function changes. The outcome will be recorded as the occurrence of acute kidney injury during the postoperative 7-day period.
Trial sites (1)
Facility
City
Region
Status
Nanjing First Hospital, Nanjing Medical University
Nanjing
Jiangsu
More Nanjing First Hospital, Nanjing Medical University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.